Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HL-CA-1600, Hemolung RAS Registry. A Retrospective Registry Involving Voluntary Reporting of De-identified, Standard of Care Data Following the Commercial Use of the Hemolung Respiratory Assist System (RAS)

NCT01855815 is registered in ClinicalTrials.gov with Alung Technologies as lead sponsor.

NCT NCT01855815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01855815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HL-CA-1600, Hemolung RAS Registry. A Retrospective Registry Involving Voluntary Reporting of De-identified, Standard of Care Data Following the Commercial Use of the Hemolung Respiratory Assist System (RAS)
Lead sponsor
Alung Technologies
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2013
Completion date
December 31, 2019
Enrollment
99 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute hypercapnic respiratory failure